Aristides Anastasakis

2.2k total citations · 1 hit paper
12 papers, 1.1k citations indexed

About

Aristides Anastasakis is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Aristides Anastasakis has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 1 paper in Surgery and 1 paper in Molecular Biology. Recurrent topics in Aristides Anastasakis's work include Cardiomyopathy and Myosin Studies (10 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiac pacing and defibrillation studies (3 papers). Aristides Anastasakis is often cited by papers focused on Cardiomyopathy and Myosin Studies (10 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiac pacing and defibrillation studies (3 papers). Aristides Anastasakis collaborates with scholars based in Greece, Italy and Spain. Aristides Anastasakis's co-authors include Perry Elliott, Juan R. Gimeno, Constantinos O’Mahony, Claudio Rapezzi, Elena Biagini, Lorenzo Monserrat, Giuseppe Limongelli, Menelaos Pavlou, William J. McKenna and Rumana Omar and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

Aristides Anastasakis

12 papers receiving 1.1k citations

Hit Papers

A novel clinical risk pre... 2013 2026 2017 2021 2013 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Aristides Anastasakis 1.0k 145 98 83 57 12 1.1k
Federica Re 1.0k 1.0× 147 1.0× 59 0.6× 326 3.9× 63 1.1× 45 1.1k
Shaughan Dickie 1.7k 1.6× 272 1.9× 132 1.3× 229 2.8× 96 1.7× 20 1.8k
Makoto Okawa 811 0.8× 130 0.9× 130 1.3× 101 1.2× 66 1.2× 40 910
Gil Moravsky 513 0.5× 71 0.5× 103 1.1× 77 0.9× 98 1.7× 20 565
Federica Ramani 685 0.7× 30 0.2× 114 1.2× 99 1.2× 48 0.8× 24 754
P Gregor 228 0.2× 64 0.4× 61 0.6× 46 0.6× 55 1.0× 62 323
Virginia B. Hebl 451 0.4× 85 0.6× 66 0.7× 116 1.4× 21 0.4× 16 561
Leena Sulaibeekh 563 0.5× 42 0.3× 71 0.7× 44 0.5× 166 2.9× 5 605
Susan Clark 563 0.5× 43 0.3× 76 0.8× 45 0.5× 166 2.9× 6 618
Kayo Hayato 418 0.4× 61 0.4× 54 0.6× 50 0.6× 34 0.6× 15 464

Countries citing papers authored by Aristides Anastasakis

Since Specialization
Citations

This map shows the geographic impact of Aristides Anastasakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aristides Anastasakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aristides Anastasakis more than expected).

Fields of papers citing papers by Aristides Anastasakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aristides Anastasakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aristides Anastasakis. The network helps show where Aristides Anastasakis may publish in the future.

Co-authorship network of co-authors of Aristides Anastasakis

This figure shows the co-authorship network connecting the top 25 collaborators of Aristides Anastasakis. A scholar is included among the top collaborators of Aristides Anastasakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aristides Anastasakis. Aristides Anastasakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Green, Nathan, Yang Chen, Constantinos O’Mahony, et al.. (2023). A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making. European Heart Journal - Quality of Care and Clinical Outcomes. 10(4). 285–293. 4 indexed citations
2.
Vassilikos, Vassilios, Efstathios D. Pagourelias, Νikolaos Raikos, et al.. (2020). Impact of social containment measures on cardiovascular admissions and sudden cardiac death rates during Coronavirus Disease (COVID-19) outbreak in Greece. SHILAP Revista de lepidopterología. 62(4). 318–319. 4 indexed citations
3.
Mazzanti, Andrea, Alessandro Trancuccio, Eleonora Pagan, et al.. (2020). Novel insights on Andersen-Tawil syndrome type 1. European Heart Journal. 41(Supplement_2). 1 indexed citations
4.
Lorenzini, Massimiliano, Zacharias Anastasiou, Constantinos O’Mahony, et al.. (2019). Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population. JAMA Cardiology. 5(1). 73–73. 72 indexed citations
5.
Dilaveris, Polychronis, K. Gatzoulis, C. Antoniou, et al.. (2017). P944Prospective study of implantable cardioverter-defibrillator activation in hypertrophic cardiomyopathy patients in greece. EP Europace. 19(suppl_3). iii193–iii193. 1 indexed citations
6.
O’Mahony, Constantinos, Fatima Jichi, Lorenzo Monserrat, et al.. (2016). Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy. Circulation Arrhythmia and Electrophysiology. 9(6). 14 indexed citations
7.
Guttmann, Oliver, Menelaos Pavlou, Constantinos O’Mahony, et al.. (2016). Predictors of atrial fibrillation in hypertrophic cardiomyopathy. Heart. 103(9). 672–678. 72 indexed citations
8.
Elliott, Perry, Aristides Anastasakis, Michael A. Borger, et al.. (2015). ESC 2014 clinical practice guidelines on the diagnosis and management of hypertrophic cardiomyopathy. Revista Española de Cardiología. 68. 1 indexed citations
9.
Guttmann, Oliver, Menelaos Pavlou, Constantinos O’Mahony, et al.. (2015). Prediction of Thrombo-Embolic Risk in Patients with Hypertrophic Cardiomyopathy (HCM Risk-CVA). European Journal of Heart Failure. 17(8). 837–845. 104 indexed citations
11.
O’Mahony, Constantinos, Fatima Jichi, Menelaos Pavlou, et al.. (2013). A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). European Heart Journal. 35(30). 2010–2020. 737 indexed citations breakdown →
12.
Kyriakidis, Michael, John Dernellis, Aristides Androulakis, et al.. (1997). Changes in Phasic Coronary Blood Flow Velocity Profile and Relative Coronary Flow Reserve in Patients With Hypertrophic Obstructive Cardiomyopathy. Circulation. 96(3). 834–841. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026